Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Struct Biol ; 202(2): 113-117, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29288126

RESUMO

Clostridium botulinum neurotoxins (BoNTs) cause the life-threatening condition, botulism. However, while they have the potential to cause serious harm, they are increasingly being utilised for therapeutic applications. BoNTs comprise of seven distinct serotypes termed BoNT/A through BoNT/G, with the most widely characterised being sub-serotype BoNT/A1. Each BoNT consists of three structurally distinct domains, a binding domain (HC), a translocation domain (HN), and a proteolytic domain (LC). The HC domain is responsible for the highly specific targeting of the neurotoxin to neuronal cell membranes. Here, we present two high-resolution structures of the binding domain of subtype BoNT/A3 (HC/A3) and BoNT/A4 (HC/A4) at 1.6 Šand 1.34 Šresolution, respectively. The structures of both proteins share a high degree of similarity to other known BoNT HC domains whilst containing some subtle differences, and are of benefit to research into therapeutic neurotoxins with novel characteristics.


Assuntos
Toxinas Botulínicas Tipo A/química , Botulismo/microbiologia , Clostridium botulinum/química , Sequência de Aminoácidos/genética , Toxinas Botulínicas Tipo A/genética , Botulismo/genética , Clostridium botulinum/genética , Clostridium botulinum/patogenicidade , Humanos , Neurônios/efeitos dos fármacos , Ligação Proteica , Domínios Proteicos/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA